Daniel E Furst

Daniel E Furst

UNVERIFIED PROFILE

Are you Daniel E Furst?   Register this Author

Register author
Daniel E Furst

Daniel E Furst

Publications by authors named "Daniel E Furst"

Are you Daniel E Furst?   Register this Author

100Publications

4083Reads

45Profile Views

Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II.

J Rheumatol 2019 Oct 15;46(10):1316-1325. Epub 2019 Feb 15.

From the Department of Medicine and Department of Radiology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California; Department of Biomathematics, University of California, Los Angeles, California; Department of Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697251PMC
October 2019

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.

J Rheumatol 2019 Sep 15;46(9):1159-1163. Epub 2019 Jan 15.

From the Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; The Rheumatology Research Unit, Department of Rheumatology, Odense University Hospital; Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute; Children's Hospital of Eastern Ontario Research Institute; Department of Pediatrics and School of Rehabilitation Sciences, University of Ottawa, Ottawa; Institute for Work and Health, Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute and the Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health; Department of Epidemiology and Biostatistics; Amsterdam Rheumatology and Immunology Center; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam; Department of Rheumatology, and Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre; Care and Public Health Research Institute, Maastricht University, Maastricht; University of Twente, Department of Psychology, Health and Technology, Enschede, the Netherlands; Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles; Medicine Service, VA Medical Center, Birmingham; Department of Medicine, School of Medicine, University of Alabama, and Division of Epidemiology, School of Public Health, University of Alabama, Birmingham, Alabama; Department of Rehabilitation and Movement Science, College of Nursing and Health Sciences, University of Vermont, Burlington, Vermont; University of Washington, Seattle, Washington, USA; Swiss Paraplegic Research, Nottwil, Switzerland; Université de Lorraine, EA 4360 Approches Épidémiologiques et Psychologiques (APEMAC), Nancy, France; University of Florence, Florence, Italy; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria; European Medicines Agency, London, UK; Faculty of Medicine and Health University of Sydney and Department of Rheumatology, Royal North Shore Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181081DOI Listing
September 2019

Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials.

J Rheumatol 2019 Sep 1;46(9):1173-1178. Epub 2019 May 1.

From the Clinical Epidemiology, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Denmark; David Geffen School of Medicine, Division of Rheumatology, University of California at Los Angeles (UCLA), Los Angeles; Division of Immunology and Rheumatology, Stanford University, Stanford; Healthy Motivation, and Global Alliance for Musculoskeletal Health, Bone and Joint Decade, Santa Barbara, California; Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Division of Rheumatology, Duke University School of Medicine, Durham; UCB Bio Sciences Inc., Raleigh, North Carolina; Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey; SDG LLC, Cambridge, Massachusetts, USA; Department of Family Medicine, McGill University, Montreal, Quebec; Health Services Research, Department of Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Institute of Translational Medicine, University of Liverpool, Liverpool, UK; Department of Epidemiology and Biostatistics, Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam, the Netherlands; Centre for Health Policy Melbourne School of Population and Global Health, University of Melbourne, Melbourne; University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190196DOI Listing
September 2019

Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis.

J Rheumatol 2019 Sep 1. Epub 2019 Sep 1.

From the Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology and Scleroderma Unit AOUC, Florence Italy; Department of Family Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; Faculty of Medicine, Alexandria University, Alexandria, Egypt; Department of Experimental and Clinical Medicine, University of Florence, and Department of Emergency, Division of Medicine IV AOUC, Florence, Italy; Department of Maternal-Neonatal Care, DAIMI, Careggi University Hospital, Florence, Italy; Los Angeles, USA UCLA (emeritus); University of Washington, Seattle, Washington; University of Florence, Florence, Italy. Address correspondence to Jelena Blagojevic, Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology and Scleroderma Unit AOUC, Florence Italy, Villa Monna Tessa, viale Pieraccini 18, 50139 Florence, Italy. E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181460DOI Listing
September 2019

The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs.

Eur J Intern Med 2019 Sep 17. Epub 2019 Sep 17.

Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Via Delle Oblate 4, 50134 Florence, Italy; Department of Geriatric Medicine, Division of Rheumatology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2019.09.001DOI Listing
September 2019

Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis.

J Rheumatol 2019 Jun 15;46(6):603-608. Epub 2018 Nov 15.

From the Department of Experimental and Clinical Medicine, and Department of Public Health, University of Florence; Department of Geriatric Medicine, Division of Rheumatology Azienda Ospedaliero-Universitaria Careggi (AOUC), Florence, Italy; the Centre for Rheumatology and Connective Tissue Diseases, University College London (UCL), Division of Medicine, London, UK; Rheumatology and Rehabilitation Department, Assiut University Hospital, Assiut, Egypt; Department of Rheumatology, Institute for Research and Health Care (IRCCS) Policlinico San Matteo Foundation, Pavia, Italy; Department of Medicine Statistics Core, and Division of Rheumatology, Department of Medicine, University of California at Los Angeles, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.171486
Publisher Site
http://dx.doi.org/10.3899/jrheum.171486DOI Listing
June 2019

Targeting inflammatory pathways in axial spondyloarthritis.

Arthritis Res Ther 2019 Jun 4;21(1):135. Epub 2019 Jun 4.

Department of Medicine, Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-019-1885-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549293PMC
June 2019

Questioning a publication bias between industry-funded and non-industry-funded randomized controlled trials on biological and small molecule therapy for rheumatoid arthritis.

Semin Arthritis Rheum 2019 Jun 8. Epub 2019 Jun 8.

Department of Pediatric Rheumatology, Schneider Medical Center of Israel, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2019.06.006DOI Listing
June 2019

Genetic and inflammatory factors associated with psoriatic arthritis: Relevance to diagnosis and management.

Clin Immunol 2019 May 6;202:59-75. Epub 2019 Feb 6.

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216616183067
Publisher Site
http://dx.doi.org/10.1016/j.clim.2019.02.001DOI Listing
May 2019

Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus.

Semin Arthritis Rheum 2019 Feb 4;48(4):686-693. Epub 2018 Apr 4.

Department of Experimental and Clinical Medicine, University of Florence & Department of Geriatric Medicine, Division of Rheumatology AOUC, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2018.03.019DOI Listing
February 2019

Timely renal transplantation for scleroderma end-stage kidney disease patients can improve outcomes and quality of life.

Ann Transl Med 2019 Feb;7(3):60

Department of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2018.12.64DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389581PMC
February 2019

Telomere dysfunction-related serological markers and oxidative stress markers in rheumatoid arthritis patients: correlation with diseases activity.

Clin Rheumatol 2018 Dec 16;37(12):3239-3246. Epub 2018 Oct 16.

Department of Medicine, Division of Rheumatology, University of California in Los Angeles (emeritus), Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-018-4318-5DOI Listing
December 2018

On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.

Rheumatol Int 2018 12 20;38(12):2225-2231. Epub 2018 Oct 20.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00296-018-4173-3
Publisher Site
http://dx.doi.org/10.1007/s00296-018-4173-3DOI Listing
December 2018

Long-Term Safety of Rituximab in Rheumatoid Arthritis: Analysis From the SUNSTONE Registry.

Arthritis Care Res (Hoboken) 2018 Oct 8. Epub 2018 Oct 8.

University of California, Los Angeles, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/acr.23781
Publisher Site
http://dx.doi.org/10.1002/acr.23781DOI Listing
October 2018

A Case Series on Patients on Tofacitinib in Combination With a Biologic.

J Clin Rheumatol 2018 Sep;24(6):349-351

Department of Rheumatology David Geffen School of Medicine University of California Los Angeles, CA Department of Rheumatology David Geffen School of Medicine University of California Los Angeles, CA Department of Rheumatology David Geffen School of Medicine University of California Los Angeles, CA Pacific Arthritis Los Angeles, CA.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00124743-201809000-0001
Publisher Site
http://dx.doi.org/10.1097/RHU.0000000000000663DOI Listing
September 2018

High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference.

Arthritis Res Ther 2018 08 16;20(1):181. Epub 2018 Aug 16.

Department of Immunology and Rheumatology, the Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-018-1686-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097225PMC
August 2018

Sirukumab for the treatment of rheumatoid arthritis: update on sirukumab, 2018.

Expert Rev Clin Immunol 2018 07 4;14(7):539-547. Epub 2018 Jul 4.

c Geffen School of Medicine at the University of California in Los Angeles (Emeritus), California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1744666X.2018.1487291DOI Listing
July 2018

Ultrasound characterization of cutaneous ulcers in systemic sclerosis.

Clin Rheumatol 2018 Jun 10;37(6):1555-1561. Epub 2018 Mar 10.

Department of Medicine, Rheumatology Division, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-018-3986-5DOI Listing
June 2018

Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study.

J Rheumatol 2018 03 1;45(3):405-410. Epub 2017 Nov 1.

From the Robert Wood Johnson (RWJ) Medical School Scleroderma Program, New Brunswick; Celgene Corp., Summit, New Jersey; Department of Rheumatology, University of Pittsburgh, Pittsburgh, Pennsylvania; David Geffen School of Medicine at the University of California at Los Angeles (UCLA), Los Angeles, California; Georgetown University Medical Center, Washington, DC, USA; Centre for Rheumatology and Connective Tissue Disease, London, UK; The Queen Elizabeth Hospital and University of Adelaide, Adelaide, Australia; Research Rheumatology Institute n.a. V.A. Nassonova, Moscow, Russia; Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161040DOI Listing
March 2018

Autologous Stem-Cell Transplantation for Severe Scleroderma.

N Engl J Med 2018 03;378(11):1066-1067

University of California, Los Angeles, Los Angeles, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1801275DOI Listing
March 2018

Systemic Sclerosis Trial Design Moving Forward.

J Scleroderma Relat Disord 2016 May-Aug;1(2):177-180. Epub 2018 Jan 23.

Carl M Pearson Professor of Rheumatology, Division of Rheumatology, David Geffen School of Medicine, University of California Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/jsrd.5000198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826575PMC
January 2018

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

N Engl J Med 2018 01;378(1):35-47

From the Duke University Medical Center (K.M.S., O.C., E.W.S.C.) and RTI International (D.W.), Durham, and Rho Federal Systems Division, Chapel Hill (L.K.-E., A.P., B.E., S.C.) - all in North Carolina; National Institute of Allergy and Infectious Diseases, Bethesda, MD (E.A.G., B.W., L.M.G., J.S.G.); Colorado Blood Cancer Institute, Denver (P.A.M., R.A.N.); University of Texas McGovern Medical School (M.D.M.) and M.D. Anderson Cancer Center (C.H.) - both in Houston; Vanderbilt University, Nashville (L.J.C., K.P.); University of Michigan, Ann Arbor (D.K., J.R.S.); Case Western Reserve University and University Hospitals, Cleveland (R.J.F.); University of Alabama, Birmingham (S.M.); Boston University, Boston (R.W.S.); University of Virginia, Charlottesville (K.B.); University of Washington (M.H.W., D.E.F.) and the Fred Hutchinson Cancer Research Center (G.E.G., S.H.) - both in Seattle; University of California, Los Angeles, Los Angeles (J.G., S.K., D.E.F.); City of Hope National Medical Center, Duarte, CA (S.F.); Medical University of South Carolina, Charleston (R.M.S.); Mayo Clinic, Scottsdale, AZ (L.G.); University of Calgary, Calgary, AB, Canada (J.S., S.L.); Washington University, St. Louis (R.B.); Medical College of Wisconsin, Milwaukee (M.E.C., C.K.-T.); Ottawa Hospital Research Institute, Ottawa (C.B.); University of Pittsburgh, Pittsburgh (T.M., R.T.D.); and University of Toledo Medical Center, Toledo, OH (M.B.K.).

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846574PMC
http://dx.doi.org/10.1056/nejmoa1703327DOI Listing
January 2018

Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.

J Rheumatol 2017 Dec 15;44(12):1916-1919. Epub 2016 Oct 15.

From the Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Department of Medicine, School of Epidemiology, Public Health and Community Medicine, University of Ottawa, Ottawa, Ontario; Department of Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada; Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Division of Immunology and Rheumatology, Stanford University, Stanford, California; David Geffen School of Medicine, Division of Rheumatology, University of California at Los Angeles (UCLA); Healthy Motivation, and Global Alliance for Musculoskeletal Health, Bone and Joint Decade, Santa Barbara, California; Strategic Drug Development, Advisory Services, Quintiles and Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; SDG LLC, Cambridge, Massachusetts, USA; Institute of Translational Medicine, University of Liverpool, Liverpool, UK; Department of Epidemiology and Biostatistics and the EMGO Institute for Health and Care Research, Amsterdam; Department of Epidemiology and Biostatistics, Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam, the Netherlands; Centre for Health Policy Melbourne School of Population and Global Health, University of Melbourne, Australia.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.161105
Publisher Site
http://dx.doi.org/10.3899/jrheum.161105DOI Listing
December 2017

Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center.

Joint Bone Spine 2017 12 5;84(6):747-748. Epub 2016 Dec 5.

Department of Experimental and Clinical Medicine, University of Florence, Viale Gaetano Pieraccini 18, 50134 Florence, Italy; Department of Geriatric Medicine, Division of Rheumatology AOUC, University of Florence, Viale Gaetano Pieraccini 18, 50134 Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbspin.2016.10.002DOI Listing
December 2017

High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis.

Semin Arthritis Rheum 2017 12 19;47(3):403-408. Epub 2017 May 19.

Department of Medicine, Division of Rheumatology, University of California in Los Angeles(emeritus), Los Angeles, California; Department of Rheumatology, Division of Rheumatology, University of Washington, Seattle Washington; Division of Rheumatology and Experimental Medicine, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2017.05.005DOI Listing
December 2017

An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.

J Rheumatol 2017 Nov 1;44(11):1734-1739. Epub 2017 May 1.

From the Empowerment, Participation and Social Integration Unit, Swiss Paraplegic Research, Nottwil, Switzerland; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre; CAPHRI Research Institute, Maastricht University, Maastricht; Department of Psychology, Health and Technology, University of Twente, Enschede; Department of Rheumatology, and Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, the Netherlands; Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, and Healthy Motivation, Santa Barbara, California; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Faculty of Health and Applied Sciences, University of the West of England, Bristol; Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, UK; Division of Rheumatology, Department of Medicine, University of Ottawa and Ottawa Hospital; Centre for Global Health, Institute of Population Health, University of Ottawa and Ottawa Hospital; Department of Clinical Epidemiology, Ottawa Hospital Research Institute; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital; Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute, and Departments of Occupational Science and Occupational Therapy, University of Toronto, Toronto, Ontario, Canada; Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany; University of Lorraine, EA 4360 APEMAC, Nancy, France; Institute of Bone and Joint Research, University of Sydney; Rheumatology and Musculoskeletal Epidemiology, Sydney Medical School, Sydney; Department of Rheumatology, Royal North Shore Hospital, St Leonards, Australia.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.161200
Publisher Site
http://dx.doi.org/10.3899/jrheum.161200DOI Listing
November 2017

Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.

J Rheumatol 2017 Oct 15;44(10):1536-1543. Epub 2017 Aug 15.

From McGill University, Montreal, Quebec; University of British Columbia, Vancouver, British Columbia, Canada; Johns Hopkins University, Baltimore, Maryland; Hospital for Special Surgery, New York, New York; University of California, Los Angeles; Healthy Motivation, Santa Barbara, California, USA; Cardiff University, Cardiff; University of the West of England, Bristol, UK; Schlosspark-Klinik University Medicine, Berlin, Germany; Parker Institute, Copenhagen University, Copenhagen, Denmark; Sint Maartenskliniek, Nijmege; Vrije Universiteit (VU), Amsterdam, the Netherlands; Pierre et Marie Curie University, Paris; University of Lorraine, Lorraine, France; University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649670PMC
October 2017

Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs.

Int J Rheumatol 2017 31;2017:9614241. Epub 2017 Oct 31.

Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/9614241DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684575PMC
October 2017

Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control.

Clin Rheumatol 2017 Sep 25;36(9):2045-2054. Epub 2017 Feb 25.

Health Economics & Outcomes Research, Immunology & Dermatology Business Unit, Novartis Pharmaceuticals Corporation, East Hanover, NJ, 07936, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-017-3578-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554474PMC
September 2017

Points to consider for designing trials in systemic sclerosis patients with arthritic involvement.

Rheumatology (Oxford) 2017 09;56(suppl_5):v23-v26

Michigan Scleroderma Program, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850357PMC
September 2017

Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis.

Rheumatology (Oxford) 2017 09;56(suppl_5):v4-v11

Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850471PMC
September 2017

Muscle involvement in systemic sclerosis: points to consider in clinical trials.

Rheumatology (Oxford) 2017 09;56(suppl_5):v38-v44

Department of Rheumatology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex196DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850276PMC
September 2017

Points to consider when doing a trial primarily involving the heart.

Rheumatology (Oxford) 2017 09;56(suppl_5):v12-v16

Department of Cardiology, Cochin Hospital, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850499PMC
September 2017

Points to consider-Raynaud's phenomenon in systemic sclerosis.

Rheumatology (Oxford) 2017 09;56(suppl_5):v45-v48

The University of Manchester, Salford Royal NHS Foundation Trust, Manchester and NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex199DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850109PMC
September 2017

Points to consider for skin ulcers in systemic sclerosis.

Rheumatology (Oxford) 2017 09;56(suppl_5):v67-v71

Department of Clinical and Experimental Medicine, Division of Rheumatology, University of Florence, AOU Careggi, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850787PMC
September 2017

Points to consider in renal involvement in systemic sclerosis.

Rheumatology (Oxford) 2017 09;56(suppl_5):v49-v52

Department of Clinical and Experimental Medicine, Division of Rheumatology, University of Florence, AOU Careggi, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850113PMC
September 2017

Assessment of skin involvement in systemic sclerosis.

Rheumatology (Oxford) 2017 09;56(suppl_5):v53-v66

Department of Rheumatology and Immunology, Medical School, University of Pécs, Pécs.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850338PMC
September 2017

Interstitial lung disease points to consider for clinical trials in systemic sclerosis.

Rheumatology (Oxford) 2017 09;56(suppl_5):v27-v32

Department of Medicine, Royal Brompton Hospital, Faculty of Medicine, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850349PMC
September 2017

Update of sarilumb to treat rheumatoid arthritis based on randomized clinical trials: a systematic review.

Expert Rev Clin Immunol 2017 08;13(8):741-752

b Department of Medicine, Division of Rheumatology , University of California Los Angeles , Los Angeles , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1744666X.2017.1351297DOI Listing
August 2017

Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials.

Semin Arthritis Rheum 2017 06 14;46(6):699-708. Epub 2016 Sep 14.

Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg og Frederiksberg Hospital, The Capital Region, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2016.09.003DOI Listing
June 2017

Structural Validity of the Rheumatology Attitudes Index in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study.

J Rheumatol 2017 06 15;44(6):795-798. Epub 2017 Apr 15.

From the San Diego State University (SDSU)/University of California (UC) San Diego Joint Doctoral Program in Clinical Psychology, Department of Psychology, San Diego; Department of Psychology, California State University, Dominguez Hills; SDSU, Department of Psychology, San Diego; David Geffen School of Medicine, University of California, Los Angeles (UCLA) School of Medicine, Los Angeles, California; University of Michigan Health System, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457305PMC
June 2017

Highlights of Skin Disease Education Foundation's 41st Annual Hawaii Dermatology Seminar™.

Semin Cutan Med Surg 2017 Jun;36(4S):S52-S59

Clinical Instructor, Department of Dermatology, The University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12788/j.sder.2017.026DOI Listing
June 2017

Biosimilars and the extrapolation of indications for inflammatory conditions.

Biologics 2017 17;11:5-11. Epub 2017 Feb 17.

Pfizer Inc, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BTT.S124476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322938PMC
February 2017

Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.

Clin Exp Rheumatol 2016 Sep-Oct;34 Suppl 100(5):92-99. Epub 2016 Aug 1.

Lady Davis Inst.Med.Res, Jewish Gen.Hosp; Depts. Educational & Counselling Psychology, Psychiatry, McGill Univ; Dept.of Medicine, McGill Univ; Depts. Psychology, Epidemiology, Biostats & Occupational Health, School Nursing, McGill Univ, Montreal, Canada.

View Article

Download full-text PDF

Source
January 2017

Biological agents in polyarticular juvenile idiopathic arthritis: A meta-analysis of randomized withdrawal trials.

Semin Arthritis Rheum 2016 12 16;46(3):312-318. Epub 2016 Jul 16.

David Geffen School of Medicine, University of California, 1000 Veteran Ave Rm 32-59, Los Angeles, CA 90025. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00490172163010
Publisher Site
http://dx.doi.org/10.1016/j.semarthrit.2016.07.001DOI Listing
December 2016

Premedication prevents infusion reactions and improves retention rate during infliximab treatment.

Clin Rheumatol 2016 Nov 19;35(11):2841-2845. Epub 2016 Jul 19.

Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Villa Monna Tessa, Viale Pieraccini 18, 50134, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-016-3351-5DOI Listing
November 2016

Scleroderma renal crisis and renal involvement in systemic sclerosis.

Nat Rev Nephrol 2016 11 19;12(11):678-691. Epub 2016 Sep 19.

Division of Rheumatology, David Geffen School of Medicine, University of California, 100 Veterans Avenue, Los Angeles, California 90025, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneph.2016.124DOI Listing
November 2016

The Responsibilites of Daily Life May Interfere With Adherence to Medications in Patients With Rheumatoid Arthritis (RA) and Systemic Sclerosis (SSc).

J Clin Rheumatol 2016 Oct;22(7):392

Global Health Research Innovation Center Department of Anthropology Miami University, Oxford, OH; and Center for Culture and Health Semel Institute for Psychiatry and Human Behavior UCLA, Los Angeles, CA Arthritis Associates of Southern California (AASC) Los Angeles, CA Division of Rheumatology University of Washington, Seattle, WA; and University of Florence Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000452DOI Listing
October 2016

Calcinosis in systemic sclerosis: subsets, distribution and complications.

Rheumatology (Oxford) 2016 09 30;55(9):1610-4. Epub 2016 May 30.

Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew193DOI Listing
September 2016

Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis.

Ann Rheum Dis 2016 Aug 10;75(8):1501-5. Epub 2016 Feb 10.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2015-208258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975847PMC
August 2016

Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set.

RMD Open 2016 26;2(1):e000225. Epub 2016 May 26.

Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA; Divisions of Clinical Epidemiology, Rheumatology, and Respiratory Clinical Trials Unit, McGill University, Montreal, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2015-000225DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885442PMC
June 2016

The Rate of Adherence to Antiarthritis Medications and Associated Factors among Patients with Rheumatoid Arthritis: A Systematic Literature Review and Metaanalysis.

J Rheumatol 2016 Mar 15;43(3):512-23. Epub 2016 Feb 15.

From the Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA); Division of General Internal Medicine and Health Services Research, UCLA, Los Angeles, California; Division of Cardiology, Department of Internal Medicine, University of Missouri, Columbia, Missouri; Department of Anthropology, Miami University, Oxford, Ohio; University of Washington, Seattle, Washington, USA; University of Florence, Florence, Italy.A. Scheiman-Elazary, MD, Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, UCLA; L. Duan, MS, Division of General Internal Medicine and Health Services Research, UCLA; Courtney Shourt, MD, Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, UCLA; H. Agrawal, MD, Division of Cardiology, Department of Internal Medicine, University of Missouri; D. Ellashof, PhD, Division of General Internal Medicine and Health Services Research, UCLA; M. Cameron-Hay, PhD, Department of Anthropology, Miami University; D.E. Furst, MD, University of Washington, and University of Florence.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141371DOI Listing
March 2016

Infection and Lupus: Which Causes Which?

Curr Rheumatol Rep 2016 Mar;18(3):13

Division of Rheumatology, University of California Los Angeles (UCLA), 1000 Veteran Ave, Room 32-59, Los Angeles, CA, 90024, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11926-016-0561
Web Search
http://link.springer.com/10.1007/s11926-016-0561-4
Publisher Site
http://dx.doi.org/10.1007/s11926-016-0561-4DOI Listing
March 2016